$8 Billion Risperdal Judgment Reduced to $6.8 Million
Category: Risperdal
More Info: Defective Drugs
The judge presiding over a Risperdal lawsuit that saw Johnson & Johnson hit with an $8 billion jury verdict has reduced the amount the company has to pay in damages to $6.8 million.
Last October, J&J was ordered to pay $8 billion in damages to a US man who claims he was not warned that taking the company’s antipsychotic Risperdal could lead to breast growth.
A jury in Philadelphia agreed with the allegation that J&J’s Janssen unit had downplayed the risk that use of Risperdal (risperidone) in male children can cause enlarged breasts, a condition known as gynaecomastia.
Continue reading...
See the original article here: https://www.pmlive.com/pharma_news/updated_j_and_js_$8bn_risperdal_judgment_reduced_to_$6.8m_1312458
About TriMark Legal Funding
TriMark Legal Funding was founded in 2003 and is one of America's leading national lawsuit funding companies. TriMark provides pre-settlement funding and post-settlement funding, sometimes called 'lawsuit loans', to injured plaintiffs throughout the United States. We offer funding on hundreds of different types of legal claims including personal injury loans, employment litigation funding, work injury accident loans, workers compensation loans, mass tort litigation funding, and multidistrict litigation funding.
We also provide immediate inheritance advance funding for heirs and beneficiaries, as well as attorney funding and law firm financing for legal practices.
| Personal Injury Lawsuits | Mass Torts |
Click here to see the original article.